Prosper Pharma Llp - Company Profile

It is a business services limited liability partnership based in Shaikpet, Telangana, India, established in 2023.
2023 Shaikpet, Telangana, India Active
Last Updated:
Access Report
About Prosper Pharma Llp

Prosper Pharma Llp, a active limited liability partnership, was established on 21 July 2023 in Shaikpet, Telangana, India. Engaging in commission trade within the business services sector, it holds LLPIN: ACC-1395. Registered under ROC Roc Hyderabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Komalli Venu Babu (Designated Partner), Aditya Chigullapally (Designated Partner), Sumanth Chatakonda (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at Plot No 131,132, Prashanthi Hills, Raidurg, Shaikpet, Telangana, 500081.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACC-1395

  • Incorporation Date

    21 July 2023

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 2 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Prosper Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Prosper Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Prosper Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Komalli Venu Babu Designated Partner 21 Jul 2023 Current
Aditya Chigullapally Designated Partner 21 Jul 2023 Current
Sumanth Chatakonda Designated Partner 21 Jul 2023 Current
Pavan Kumar Kasturi Designated Partner 06 Jul 2024 Current
Durga Sainath Talupuri Designated Partner 06 Jul 2024 Current
Durganagaraju Puppala Designated Partner 21 Jul 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Prosper Pharma Llp.

Enhance accessibility to Prosper Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Prosper Pharma Llp revenue growth over time
Prosper Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Prosper Pharma Llp?

Unlock access to Prosper Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Prosper Pharma Llp?

Unlock and access historical data on people associated with Prosper Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Prosper Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prosper Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Prosper Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Prosper Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Prosper Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    Pavan Kumar Kasturi was appointed as a Designated Partner was appointed as a Designated Partner on 06 Jul 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Durga Sainath Talupuri was appointed as a Designated Partner was appointed as a Designated Partner on 06 Jul 2024 & has been associated with this company since 1 year 8 months . was completed.

  • Director Appointment

    Komalli Venu Babu was appointed as a Designated Partner was appointed as a Designated Partner on 21 Jul 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Aditya Chigullapally was appointed as a Designated Partner was appointed as a Designated Partner on 21 Jul 2023 & has been associated with this company since 2 years 8 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Prosper Pharma Llp?

The LLPIN of Prosper Pharma Llp is ACC-1395.

Where is Prosper Pharma Llp headquartered?

Prosper Pharma Llp is headquartered at Plot No 131,132, Prashanthi Hills, Raidurg, Shaikpet, Telangana, 500081.

When was Prosper Pharma Llp incorporated?

Prosper Pharma Llp was incorporated on 21 July 2023.

Who are the current directors of Prosper Pharma Llp?

The current directors of Prosper Pharma Llp are

What is the primary industry of Prosper Pharma Llp?

The primary industry of Prosper Pharma Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available